Clinical Trials

Evotec AG and MaRS Innovation today announced the launch of Fibrocor Therapeutics LP, a Toronto-based company focused on developing first-in-class therapeutics targeting fibrotic…
Read More...

Benitec Biopharma Limited is pleased to announce that the European Commission, based on a favourable recommendation from the European Medicines Agency (EMA) Committee for Orphan…
Read More...

Sunovion Pharmaceuticals Inc. (Sunovion) announced that results of a pivotal Phase 2/3 study (SEP360-202) evaluating novel drug candidate dasotraline in children ages 6 to 12 years with…
Read More...

Shionogi & Co., Ltd. has announced that cefiderocol (S-649266), a novel siderophore cephalosporin in late-stage development, met the FDA pre-specified primary endpoint for…
Read More...

Kitov Pharmaceuticals Holdings Ltd., an innovative biopharmaceutical company, announced the expansion of its pipeline through the acquisition of a majority stake in TyrNovo Ltd., a…
Read More...

Maverick Therapeutics Inc., an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited announced that they have entered a collaboration to develop Maverick’s T-cell…
Read More...

Hutchison China MediTech Limited announces that it has initiated a Phase I trial of its novel spleen tyrosine kinase (“Syk”) inhibitor, HMPL-523, in patients with hematological…
Read More...

Emergent Technologies, Inc. (ETI) announced that its target discovery portfolio company, Pure MHC, and global biopharmaceutical company, AbbVie (NYSE:ABBV), will embark on a research…
Read More...

Zebra Biologics Inc., an emerging pre-clinical stage biotechnology company, announced that the company has entered into a collaboration with AbbVie to discover agonist antibody…
Read More...

Ipsen announced that it has entered into a definitive agreement to acquire global oncology assets from Merrimack Pharmaceuticals, including its key marketed product ONIVYDE® (irinotecan…
Read More...

Mast Therapeutics, Inc. and Savara Inc., a privately-held emerging specialty pharmaceutical company focused on the treatment of rare respiratory diseases, today announced that the two…
Read More...

San Diego based Ambrx Inc. and Suzhou based MabSpace Biosciences have agreed to collaborate on discovery and development of multiple novel ADCs in China and around the world for…
Read More...

Takeda Pharmaceutical Company Limited and PvP Biologics, Inc. announced a global agreement for the development of KumaMax, a novel enzyme designed to break down the immune-reactive…
Read More...

PTC Therapeutics, Inc. announced that its joint development program in Spinal Muscular Atrophy (SMA) with Roche and the SMA Foundation (SMAF) initiated a clinical study in infants with…
Read More...

Custopharm, Inc., a U.S. leader in generic injectable products, announced that it has acquired two paragraph IV abbreviated new drug application (ANDA) products from Perrigo Company…
Read More...

Senhwa Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to CX-4945 for the treatment of cholangiocarcinoma. CX-4945 is…
Read More...

Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immuno-therapeutic products and vaccines, today…
Read More...

Dermira, Inc., a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of patients with…
Read More...

Marinus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced that…
Read More...

Drug firm Lupin has received final approval from the US health regulator to market cevimeline hydrochloride capsules, used for treatment of symptoms of dry mouth in patients with…
Read More...